Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 119

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1
Chunk 119
---
 at fair value on a recurring basis and their
fair value hierarchy as of December 31, 2024 and 2023:

 Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

    December 31, 2024 
    Level 1  
    Level 2  
    Level 3  
    Carrying Value 
  
    Assets 

    Marketable Securities: 

    United States Treasury Bonds 
    $—  
    $—  
    $—  
    $— 
  
    Total Assets 
    $—  
    $—  
    $—  
    $— 
  
    Liabilities 

    Derivative Liability - Warrants 
    $—  
    $—  
    $25,281  
    $25,281 
  
    Derivative Liability - Accelerated feature 
     —  
     —  
     —  
     — 
  
    Convertible Note 
    $—  
    $—  
    $684,205  
    $684,205 
  
    Total Liabilities 
    $—  
    $—  
    $709,486  
    $709,486 

    December 31, 2023 
    Level 1  
    Level 2  
    Level 3  
    Carrying Value 
  
    Assets 

    Marketable Securities: 

    United States Treasury Bonds 
    $2,887,215  
    $—  
    $—  
    $2,887,215 
  
    Total Assets 
    $2,887,215  
    $—  
    $—  
    $2,887,215 
  
    Liabilities 

    Derivative Liability - Warrants 
    $—  
    $—  
    $410,660  
    $410,660 
  
    Derivative Liability - Accelerated feature 
     —  
     —  
     3,852  
     3,852 
  
    Derivative Liability 
     —  
     —  
     3,852  
     3,852 

    Total Liabilities 
    $—  
    $—  
    $414,512  
    $414,512 

See
Note 5 and Note 7 for additional disclosures related to